Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,859 public trials 2,108 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

NCT02598557

Conditions
Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • Galliera Hospital Genoa, Italy
View Trial Details
Completed

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

NCT00820248

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 19 locations
View Trial Details
Completed

Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment

NCT03200717

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site Graz, Austria
  • Novartis Investigative Site Salzburg, Austria
View all 22 locations
View Trial Details
Completed

A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer

NCT02426125

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • St. Jude Medical Center Fullerton, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
View all 141 locations
View Trial Details
Completed

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

NCT02034110

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Blood Protein Disorders, +35 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Santa Monica, California, United States
  • Novartis Investigative Site Bethesda, Maryland, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View all 41 locations
View Trial Details
Completed

Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)

NCT03513705

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • Academic Medical Center Amsterdam, Netherlands
  • Onze Lieve Vrouwen Gasthuis Amsterdam, Netherlands
  • VU Medical Center Amsterdam, Netherlands
View all 17 locations
View Trial Details
Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details

Related conditions